Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Cell Death and Differentiation
|
January 31, 2015
CXXC5 is a negative-feedback regulator of the Wnt/β-catenin pathway involved in osteoblast differentiation
H-Y Kim, J-Y Yoon, J-H Yun, et al.
Current Oncology (Toronto, Ont.)
|
April 25, 2015
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment
J C Easaw, M A Shea-Budgell, C M J Wu, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Systemic adjuvant and perioperative chemotherapy following curative-intent liver metastasectomy in colorectal cancer-is it justified?
R D Peixoto, J M Loree, T A Miranda, et al.
Cellular Microbiology
|
November 1, 2017
Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase
Jessamine G Goh, Sharada Ravikumar, Mar Soe Win, et al.
ESMO Open
|
January 10, 2022
The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey series
K H J Lim, K Murali, E Thorne, et al.
Neuroscience
|
March 6, 2007
Tau overexpression in transgenic mice induces glycogen synthase kinase 3beta and beta-catenin phosphorylation
S B Shim, H J Lim, K R Chae, et al.
Transplantation Proceedings
|
May 29, 2016
Health-Related Quality of Life of Kidney Transplantation Patients: Results from the KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT) Study
H J Lim, T Y Koo, J Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 30, 2016
Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
M R Jones, K A Schrader, Y Shen, et al.
International Journal of Molecular Sciences
|
March 29, 2023
Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study
E Titmuss, K Milne, M R Jones, et al.
International Journal of Molecular Sciences
|
November 27, 2024
Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 5869
E Titmuss, K Milne, M R Jones, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Cell Death and Differentiation
|
January 31, 2015
CXXC5 is a negative-feedback regulator of the Wnt/β-catenin pathway involved in osteoblast differentiation
H-Y Kim, J-Y Yoon, J-H Yun, et al.
Current Oncology (Toronto, Ont.)
|
April 25, 2015
Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment
J C Easaw, M A Shea-Budgell, C M J Wu, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Systemic adjuvant and perioperative chemotherapy following curative-intent liver metastasectomy in colorectal cancer-is it justified?
R D Peixoto, J M Loree, T A Miranda, et al.
Cellular Microbiology
|
November 1, 2017
Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase
Jessamine G Goh, Sharada Ravikumar, Mar Soe Win, et al.
ESMO Open
|
January 10, 2022
The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey series
K H J Lim, K Murali, E Thorne, et al.
Neuroscience
|
March 6, 2007
Tau overexpression in transgenic mice induces glycogen synthase kinase 3beta and beta-catenin phosphorylation
S B Shim, H J Lim, K R Chae, et al.
Transplantation Proceedings
|
May 29, 2016
Health-Related Quality of Life of Kidney Transplantation Patients: Results from the KoreaN Cohort Study for Outcome in Patients With Kidney Transplantation (KNOW-KT) Study
H J Lim, T Y Koo, J Lee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 30, 2016
Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
M R Jones, K A Schrader, Y Shen, et al.
International Journal of Molecular Sciences
|
March 29, 2023
Immune Activation following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study
E Titmuss, K Milne, M R Jones, et al.
International Journal of Molecular Sciences
|
November 27, 2024
Correction: Titmuss et al. Immune Activation Following Irbesartan Treatment in a Colorectal Cancer Patient: A Case Study. <i>Int. J. Mol. Sci.</i> 2023, <i>24</i>, 5869
E Titmuss, K Milne, M R Jones, et al.
Page
of 8